Abstract
Purpose
Diaphragmatic dysfunction contributes to exercise intolerance in chronic obstructive pulmonary disease (COPD). Although diaphragmatic excursion during deep breathing (DEmax) is associated with exercise capacity, the relationship between computed tomography (CT)-derived diaphragm morphology and diaphragmatic function remains unclear. We investigated the association of CT-derived diaphragmatic crus thickness with diaphragmatic excursion and exercise capacity in COPD.
Methods
This retrospective single-centre study included 100 patients with stable COPD who underwent chest CT, spirometry, ultrasonographic assessment of DEmax, and 6-minute walk distance (6MWD) testing. Diaphragmatic crus thickness was measured on axial CT images, and the diaphragmatic thickness index (DTI) was calculated after adjustment for body mass index. Multivariable linear regression analyses were performed to identify factors independently associated with DEmax and 6MWD. Patients were stratified according to DTI and DEmax to evaluate combined structural and functional diaphragm phenotypes.
Results
In multivariable analyses, DTI was independently associated with DEmax (β = 0.57, p < 0.001) and 6MWD (β = 0.25, p < 0.01) after adjustment for age, pulmonary function, and skeletal muscle indices. The combined low-DTI/low- DEmax phenotype was independently associated with reduced exercise capacity (6MWD < 350 m; odds ratio 14.89, 95% confidence interval 3.51–87.89, p < 0.001).
Conclusion
CT-derived diaphragmatic thickness was independently associated with diaphragmatic excursion and exercise capacity in COPD. Combined structural and functional diaphragm assessment identified patients with markedly reduced exercise capacity, suggesting a role for integrated diaphragm evaluation in functional risk stratification.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00408-026-00915-w.
Keywords: Chronic obstructive pulmonary disease, Diaphragmatic crus thickness, Diaphragm, Computed tomography, Ultrasonography, Exercise capacity
Introduction
Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation and various extrapulmonary manifestations that contribute to exercise intolerance and poor prognosis. Exercise limitation in COPD is multifactorial and involves dynamic hyperinflation, skeletal muscle dysfunction, circulatory impairment, and respiratory muscle dysfunction [1–5]. Among these factors, diaphragmatic dysfunction caused by lung hyperinflation is recognised as a major pathophysiological feature of COPD [6–9]. Hyperinflation leads to diaphragmatic flattening, shortening of muscle fibres, and reduced contractile efficiency, resulting in impaired diaphragmatic function during exercise and daily activities.
Recently, ultrasonography has emerged as a non-invasive and practical method for directly evaluating diaphragmatic function. Diaphragmatic excursion measured by ultrasound has been increasingly used as a functional marker of diaphragmatic performance in chronic respiratory diseases. We previously demonstrated that diaphragmatic excursion during deep breathing (DEmax) is significantly associated with exercise capacity and dynamic hyperinflation in patients with COPD [10]. Furthermore, we reported that DEmax correlates with improvements in exercise tolerance following pulmonary rehabilitation, suggesting that DEmax reflects diaphragmatic functional reserve and responsiveness to rehabilitation interventions [11].
In contrast, structural assessment of the diaphragm in COPD remains insufficiently investigated. Computed tomography (CT), which is routinely performed in patients with COPD, enables objective evaluation of diaphragmatic morphology, particularly diaphragmatic crus muscle thickness. A recent CT-based study demonstrated alterations in diaphragmatic morphology, including diaphragmatic crus thickness, in patients with COPD [12]. In single-lung transplant recipients, restoration of normal lung mechanics after transplantation was associated with increased diaphragmatic crus thickness and improved diaphragmatic position, indicating that pulmonary pathology may influence diaphragmatic morphology [13]. However, to our knowledge, no previous study has directly investigated the relationship between ultrasound-assessed diaphragmatic excursion and CT-assessed diaphragmatic crus thickness in patients with COPD.
Clarifying the association between diaphragmatic morphology and diaphragmatic function may improve our understanding of the structural and functional mechanisms underlying diaphragmatic dysfunction in COPD. Furthermore, because chest CT is routinely obtained in clinical practice, CT-based assessment of diaphragmatic morphology may provide a practical and objective surrogate marker of diaphragmatic dysfunction and exercise intolerance. Therefore, the present study aimed to investigate the relationship between diaphragmatic excursion measured by ultrasonography and diaphragmatic crus thickness assessed by CT in patients with COPD. We also explored the association between diaphragmatic crus thickness and exercise capacity.
Materials and Methods
Study Design and Participants
This single-centre retrospective cohort study included patients with clinically stable COPD who visited the Department of Respiratory Medicine and Allergology at Kindai University Hospital and were referred for pulmonary rehabilitation between January 2018 and May 2026.
Patients were eligible if they underwent the following assessments within 3 months of DEmax measurement: spirometry, chest CT, and exercise tolerance assessment using the 6-minute walk distance (6MWD) test.
Patients with musculoskeletal disorders affecting the diaphragm or skeletal muscles, collagen vascular diseases, and concomitant cerebrovascular diseases were excluded. Because acute exacerbation data could not be reliably collected retrospectively, hospitalisation history between baseline assessment and follow-up CT evaluation was also assessed.
Of the 100 participants included in this analysis, 60 had been included in our previous report [10], whereas the remaining 40 patients were newly enrolled during the extended study period.
Measurements
Diaphragmatic crus thickness was assessed using axial chest CT images according to a previously validated CT-based measurement method [14]. At the level of the celiac artery origin, the thickness of the right and left diaphragmatic crura was measured at the anterior, middle, and posterior aspects of the vertebral body. Three measurements were obtained from each hemidiaphragm, and the mean of the six measurements was used for subsequent analysis. The mean value of these six measurements was defined as the diaphragmatic crural thickness.
To adjust for body physique, the diaphragmatic crus thickness index (DTI) was calculated by dividing the mean diaphragmatic crural thickness by body mass index (BMI) and multiplying the value by 100 (Fig. 1) [15].
Fig. 1.
Representative CT image used for the measurement of diaphragmatic crus thickness. Diaphragmatic crus thickness was measured bilaterally at the level of the celiac artery on axial CT images. Measurements were obtained at the anterior, middle, and posterior portions of each crus, and the mean value of six measurements was used for analysis. CT, computed tomography
For quantitative analysis of the erector spinae muscles (ESMs), chest CT images were reconstructed using a mediastinal setting with a reconstruction kernel of FC13. The cross-sectional area of the ESMs was measured on axial CT images using Synapse Vincent software (Fujifilm Medical, Tokyo, Japan). Regions of interest were manually traced at a predefined vertebral level, and the bilateral ESM cross-sectional area was measured according to previously described methods [16, 17]. The sum of the left and right cross-sectional areas was divided by body surface area and expressed as the body surface area adjusted ESMCSA.
All CT scans were performed during the stable phase of the disease. Chest CT scans were obtained at full inspiration in the supine position according to the institutional standard protocol [18]. Emphysema was quantified by calculating the percentage of the low attenuation area, defined by the cutoff value of − 950 HU on whole-lung CT images (Aquilion 64 scanner; Toshiba, Tokyo, Japan) using Synapse Vincent (Fujifilm Medical), as previously described [19].
The maximum inspiratory pressure (PImax) generated against an occluded airway at the residual volume was measured using respiratory muscle strength testers [20] (IOP-01; Kobata Instrument Manufacturing Ltd., Osaka, Japan).
DEmax was measured in the standing position using ultrasonography (Xario 200; Canon Medical Systems, Tokyo, Japan) because exercise capacity and activities of daily living are generally performed in the upright position, allowing diaphragmatic function to be assessed under physiologically relevant conditions. DEmax was selected because it reflects diaphragmatic mobility during inspiration and has previously been shown to be associated with exercise capacity in patients with COPD [10, 11]. According to previously described techniques, excursions of the right hemidiaphragm were measured using a 3.5-MHz convex probe [10]. Briefly, the liver was used as an acoustic window, the M-mode cursor was rotated and aligned with the axis of diaphragmatic excursion on the stored image, and the displacement was measured during three deep breaths.
The patients underwent spirometry (CHESTAC-800; Chest, Tokyo, Japan) according to the 2014 American Thoracic Society (ATS) recommendations [21] to measure forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and inspiratory capacity (IC). The FEV1% and FVC% predicted were calculated using the Global Lung Function Initiative method recommended by the 2022 European Respiratory Society (ERS)/ATS technical standard [22] and used by the Japanese Respiratory Society to calculate reference values for spirometry [23].
The 6MWD test was performed to evaluate walking capacity according to the ERS/ATS statement [24–26].
This study was approved by the ethics committee of the Kindai University School of Medicine (approval number R08-016; approved on 27 April 2026). The requirement for informed consent was waived owing to the retrospective nature of the study, and an opt-out approach was used in agreement with the institutional review board.
Sample Size
The sample size was determined based on the primary analysis of the correlation between DTI and DEmax. Assuming a moderate correlation coefficient of 0.30, a two-sided α level of 0.05, and a statistical power of 80%, at least 84 patients were required. Considering potential missing data and the planned multivariable analyses, we aimed to include approximately 100 patients with complete datasets.
Statistical Analyses
To assess the inter-rater reproducibility of CT-derived diaphragmatic crus thickness measurements, two independent evaluators measured the diaphragmatic crus thickness in a randomly selected subset of 40 patients. Inter-rater agreement was evaluated using the intraclass correlation coefficient [ICC (2,1)] and Bland–Altman analysis. Bland–Altman plots were constructed to assess systematic bias and the 95% limits of agreement. Continuous variables are presented as mean±standard deviation. Correlations between DTI and DEmax, PImax, and 6MWD were assessed using correlation analyses. Multivariable linear regression analyses were performed to identify factors independently associated with DEmax and 6MWD.
To investigate the combined effects of diaphragmatic structure and function, patients were stratified into four groups according to DTI and DEmax values using median cutoffs (HighDTI_HighDEmax, HighDTI_LowDEmax, LowDTI_HighDEmax, and LowDTI_LowDEmax). Differences in 6MWD among the four groups were analysed using one-way analysis of variance followed by Tukey–Kramer post hoc testing.
Reduced exercise capacity was defined as a 6MWD < 350 m. Logistic regression analyses with likelihood ratio χ² testing were performed to identify factors associated with reduced exercise capacity. Statistical analyses were performed using JMP Pro version 18 (SAS Institute Inc., Cary, NC, USA). A p-value < 0.05 was considered statistically significant.
Results
A total of 110 patients were screened for eligibility. Ten patients were excluded from the final analysis because of unavailable data (n = 8) or diaphragmatic paralysis (n = 2). Consequently, 100 patients with COPD were included in the final analysis (Fig. 2). No missing data were present among the analysed participants. The baseline characteristics of the study participants are summarised in Table 1. The mean age was 76.4 ± 5.8 years, and the mean FEV₁ % predicted was 56.0%±20.1%. According to the Global Initiative for Chronic Obstructive Lung Disease classification, 7 patients (7%) were classified as stage I, 50 (50%) as stage II, 26 (26%) as stage III, and 17 (17%) as stage IV.
Fig. 2.
Flow diagram of study participant selection
Table 1.
Baseline characteristics of study participants
| Baseline index | N = 100 |
|---|---|
| Age, years | 76.4 ± 5.8 |
| Body mass index, kg/m² | 22.1 ± 3.6 |
| GOLD stage I/II/III/IV, n | 7/50/26/17 |
| FEV1, L | 1.38 ± 0.50 |
| FEV1% predicted, % | 56.0 ± 20.1 |
| FVC, L | 2.94 ± 0.73 |
| FVC, % predicted, % | 92.8 ± 19.4 |
| IC, L | 2.02 ± 0.54 |
| LAA, % | 26.9 ± 14.4 |
| QMS, kgf | 29.3 ± 8.1 |
| ESMCSA, cm² | 22.0 ± 7.3 |
| PImax, cmH₂O | 57.3 ± 22.1 |
| DE at rest, mm | 15.8 ± 3.2 |
| DEmax, mm | 46.9 ± 7.8 |
| DTI | 16.3 ± 4.9 |
| CAT score | 13.6 ± 6.6 |
| 6MWD, m | 383 ± 87 |
| Borg dyspnea | 4 ± 1 |
| Borg fatigue | 3 ± 2 |
Values are presented as mean ± standard deviation
CAT, COPD Assessment Test; DE, diaphragmatic excursion at rest; DEmax, maximum diaphragmatic excursion during deep breathing; DTI, diaphragmatic crus thickness index; ESMCSA, cross-sectional area of the erector spinae muscle; FEV₁, forced expiratory volume in 1 s; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; IC, inspiratory capacity; LAA, low attenuation area; PImax, maximal inspiratory pressure; QMS, quadriceps muscle strength; 6MWD, 6-minute walk distance
Inter-rater reproducibility of diaphragmatic crus thickness measurements was good, with an ICC (2,1) of 0.80. Bland–Altman analysis demonstrated minimal systematic bias, and most measurements were distributed within the 95% limits of agreement (Figure S1).
DTI showed significant positive correlations with DEmax (r = 0.61, p < 0.001), PImax (r = 0.39, p < 0.001), and 6MWD (r = 0.51, p < 0.001) (Fig. 3 and Table S1). In the multivariable linear regression analysis, DTI remained independently associated with DEmax after adjustment for age, BMI, pulmonary function, and skeletal muscle indices (β = 0.57, p < 0.001) (Table 2). In addition, DTI was independently associated with 6MWD (β = 0.25, p < 0.01), together with DEmax and FEV1 (Table 3). To investigate the combined effects of diaphragmatic structure and function, patients were stratified into four groups according to median cutoff values of DTI (16.3) and DEmax (46.9 mm): HighDTI_HighDEmax (n = 42), LowDTI_HighDEmax (n = 11), HighDTI_LowDEmax (n = 10), and LowDTI_LowDEmax (n = 37) (Fig. 4). Significant differences in 6MWD were observed among the four groups. The LowDTI_LowDEmax group demonstrated the lowest exercise capacity and had significantly lower 6MWD than the HighDTI_HighDEmax (p < 0.001) and LowDTI_HighDEmax groups (p < 0.001). The HighDTI_LowDEmax group also showed significantly lower 6MWD than the HighDTI_HighDEmax group (p < 0.05).
Fig. 3.
Correlation between DTI and DEmax. DTI showed a significant positive correlation with DEmax (n = 100, r = 0.61, p < 0.001). DEmax, maximum diaphragmatic excursion during deep breathing; DTI, diaphragmatic crus thickness index
Table 2.
Multivariable regression analysis for DEmax
| Independent variable | B | 95% CI (B) | β | p value | VIF |
|---|---|---|---|---|---|
| DTI | 1.02 | 0.78 to 1.25 | 0.57 | p < 0.001 | 1.11 |
| Age, years | − 0.06 | − 0.24 to 0.13 | − 0.04 | 0.54 | 1.19 |
| Body mass index, kg/m² | 0.39 | 0.10 to 0.69 | 0.18 | 0.009 | 1.19 |
| FEV₁, L | 0.09 | 0.04 to 0.15 | 0.24 | p < 0.001 | 1.22 |
| ESMCSA, cm² | 0.60 | 0.32 to 0.88 | 0.30 | p < 0.001 | 1.29 |
| QMS, kgf | 0.07 | − 0.06 to 0.20 | 0.07 | 0.30 | 1.22 |
B, unstandardized regression coefficient; β, standardized regression coefficient; CI, confidence interval; DEmax, maximum diaphragmatic excursion during deep breathing; DTI, diaphragmatic crus thickness index; ESMCSA, cross-sectional area of the erector spinae muscle; FEV₁, forced expiratory volume in 1 s; QMS, quadriceps muscle strength; VIF, variance inflation factor; 6MWD, 6-minute walk distance
Table 3.
Multivariable regression analysis for 6MWD
| Independent variable | B | 95% CI (B) | β | p value | VIF |
|---|---|---|---|---|---|
| Age, years | − 2.01 | − 4.37 to 0.35 | − 0.13 | 0.10 | 1.25 |
| Body mass index, kg/m² | 3.73 | − 0.03 to 7.50 | 0.15 | 0.05 | 1.22 |
| FEV₁, L | 0.75 | 0.02 to 1.48 | 0.17 | p < 0.05 | 1.47 |
| DEmax, mm | 4.22 | 1.70 to 6.73 | 0.37 | p < 0.01 | 2.69 |
| DTI | 5.16 | 1.41 to 8.90 | 0.25 | p < 0.01 | 1.84 |
| ESMCSA, cm² | 1.04 | − 2.68 to 4.75 | 0.04 | 0.582 | 1.42 |
| QMS, kgf | 1.73 | 0.02 to 3.44 | 0.15 | p < 0.05 | 1.29 |
B, unstandardized regression coefficient; β, standardized regression coefficient; CI, confidence interval; DEmax, maximum diaphragmatic excursion during deep breathing; DTI, diaphragmatic crus thickness index; ESMCSA, cross-sectional area of the erector spinae muscle; FEV₁, forced expiratory volume in 1 s; QMS, quadriceps muscle strength; VIF, variance inflation factor; 6MWD, 6-minute walk distance
Fig. 4.
Comparison of 6MWD among the four groups stratified according to DTI and DEmax. Individual data points are shown, and circles with error bars represent the mean ± standard error. Significant differences in 6MWD were observed among the four groups. The LowDTI_LowDEmax group demonstrated the lowest exercise capacity and had significantly lower 6MWD than the HighDTI_HighDEmax (p < 0.001) and the LowDTI_HighDEmax groups (p < 0.001). The HighDTI_LowDEmax group also showed significantly lower 6MWD than the HighDTI_HighDEmax group (p < 0.05). DEmax, maximum diaphragmatic excursion during deep breathing; DTI, diaphragmatic crus thickness index; 6MWD, 6-minute walk distance
In the logistic regression analysis using reduced exercise capacity, defined as 6MWD < 350 m, as the dependent variable, DEmax was independently associated with reduced exercise capacity, whereas DTI alone was not. However, the combined LowDTI_LowDEmax phenotype remained independently associated with reduced exercise capacity after adjustment for age, BMI, FEV₁ and lower extremity muscle strength (odds ratio, 14.89; 95% confidence interval, 3.51–87.89; p < 0.001) (Table 4).
Table 4.
Multivariable logistic regression analysis for reduced exercise capacity (6MWD < 350 m)
| Variable | OR | 95% CI | p value |
|---|---|---|---|
| LowDTI_LowDEmax phenotype | 14.89 | 3.51–87.89 | p < 0.001 |
| Age, years | 1.07 | 0.94–1.24 | 0.31 |
| Body mass index, kg/m² | 0.92 | 0.74–1.13 | 0.45 |
| FEV₁, L | 0.95 | 0.93–0.98 | p < 0.01 |
| QMS, kgf | 0.85 | 0.76–0.93 | p < 0.01 |
CI, confidence interval; DTI, diaphragmatic crus thickness index; FEV₁, forced expiratory volume in 1 s; OR, odds ratio; QMS, quadriceps muscle strength; 6MWD, 6-minute walk distance
Discussion
In the present study, CT-derived DTI was significantly associated with DEmax, inspiratory muscle strength, and exercise capacity in patients with COPD. Moreover, DTI remained independently associated with both DEmax and 6MWD after adjustment for age, BMI, pulmonary function, and skeletal muscle indices. Importantly, the combined LowDTI_LowDEmax phenotype was independently associated with reduced exercise capacity, suggesting that structural and dynamic diaphragm assessments provide complementary information regarding functional impairment in COPD.
These findings are biologically plausible because chronic hyperinflation in COPD alters diaphragm geometry and impairs contractile efficiency [27, 28]. Within this context, reduced DEmax likely reflects impaired diaphragmatic mobility caused by hyperinflation-related mechanical disadvantage, whereas reduced DTI may reflect structural remodelling or loss of diaphragmatic muscle reserve. The coexistence of both abnormalities may therefore represent more advanced diaphragmatic dysfunction.
Our findings are consistent with our previous ultrasound studies showing that DEmax is associated with exercise capacity and dynamic hyperinflation and that improvement in DEmax parallels gains in exercise tolerance after pulmonary rehabilitation in patients with COPD [10, 11]. These observations suggest that DEmax reflects diaphragmatic functional reserve rather than merely static respiratory mechanics.
The present study extends these observations by demonstrating that CT-assessed diaphragmatic morphology is also associated with diaphragmatic function and ambulatory performance. Because chest CT is routinely performed in COPD management, DTI may provide clinically accessible structural information complementary to ultrasound-derived functional assessment. Furthermore, diaphragm morphology assessed by CT has been linked to airflow limitation and altered respiratory mechanics [18]. Our results further support the concept that structural assessment of the diaphragm may reflect clinically relevant respiratory muscle dysfunction in COPD.
The present findings also fit conceptually with the emerging framework of respiratory sarcopenia, which is characterised by reduced respiratory muscle mass and impaired respiratory muscle strength [29]. Although respiratory sarcopenia is generally evaluated using global respiratory pressure measures such as PImax, these measurements do not specifically assess diaphragmatic morphology or motion. In contrast, DEmax directly reflects diaphragm-specific movement, whereas DTI may represent structural muscle reserve. DEmax reflects diaphragmatic mobility during inspiration and has previously been associated with exercise capacity in patients with COPD.
Therefore, combined assessment using CT-derived DTI and ultrasound-derived DEmax may provide a more comprehensive evaluation of diaphragm dysfunction than inspiratory pressure measurements alone.
Although DTI alone was not independently associated with reduced exercise capacity in the multivariable logistic analysis, the combined LowDTI_LowDEmax phenotype remained significantly associated with reduced exercise capacity. These findings suggest that structural abnormalities may provide clinically relevant information when interpreted together with dynamic diaphragmatic dysfunction rather than as isolated findings.
From a clinical perspective, integrated diaphragm assessment may help identify patients with poor functional reserve who could benefit from intensified pulmonary rehabilitation, nutritional intervention, or closer evaluation of hyperinflation and respiratory muscle dysfunction. Because both chest CT and diaphragm ultrasonography are increasingly available in routine clinical practice, this combined approach may be feasible in real-world COPD management.
Several limitations should be acknowledged. First, this was a retrospective single-centre study with a relatively modest sample size, which may limit generalisability. Second, DTI is a relatively novel CT-derived parameter, and external validation is required before clinical application. Third, because residual volume and total lung capacity were not available, the relationship among DTI, DEmax, and static hyperinflation could not be directly evaluated. Fourth, the relatively small subgroup sizes and unequal distribution of phenotype groups may have affected the stability of logistic regression estimates, as reflected by the relatively wide confidence intervals. Finally, this study assessed diaphragm morphology quantitatively using CT but did not include direct measurements of diaphragm contractility or histological assessment of muscle quality.
In conclusion, CT-derived diaphragmatic thickness was significantly associated with diaphragmatic excursion and exercise capacity in patients with COPD. Furthermore, combined reduction in DTI and DEmax identified patients with particularly low exercise capacity. Integrating structural and dynamic diaphragm assessments may improve evaluation of respiratory muscle dysfunction and functional risk stratification in COPD.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
The authors thank the staff of the Department of Rehabilitation Medicine, Kindai University Hospital, for their support in data collection and patient care.
Author Contributions
MS: Conceptualization, Methodology, Data curation, Formal analysis, Investigation, Writing – original draft. YH: Conceptualization, Methodology, Supervision, Writing – review & editing. HM: Supervision, Methodology, Writing – review & editing. KK, HN, HMi, YT, and MN: Data curation, Investigation. ON, RY, and TK: Validation, Writing – review & editing. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.
Funding
This work was supported by JSPS KAKENHI Grant Number 22K17664.
Data Availability
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
Declarations
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Take-home message
Computed tomography–derived diaphragmatic crus thickness is independently associated with diaphragmatic excursion and exercise capacity in COPD and combined structural and functional diaphragm assessment may improve functional risk stratification.
Ethics Approval
This study was approved by the Ethics Committee of Kindai University School of Medicine (approval number R08-016).
Consent to Participate
The requirement for informed consent was waived owing to the retrospective nature of the study, and an opt-out approach was used in accordance with institutional regulations.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Vogiatzis I, Zakynthinos S (2012) Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol 2:1779–1817 [DOI] [PubMed] [Google Scholar]
- 2.O’Donnell DE (2001) Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exerc 33:S647–S655 [DOI] [PubMed] [Google Scholar]
- 3.D’Cruz RF, Wilkins D, Jolley CJ (2026) Exercise-induced dynamic hyperinflation in chronic obstructive pulmonary disease. Exp Physiol 111:2476–2484 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gea J, Orozco-Levi M, Pascual-Guardia S et al (2025) Biological mechanisms involved in muscle dysfunction in COPD: an integrative damage-regeneration-remodeling framework. Cells 14:1731 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gelinas J, Harper M, Sasso J et al (2022) Phenotyping Cardiopulmonary Exercise Limitations in Chronic Obstructive Pulmonary Disease. Front Physiol 13:816586 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hellebrandova L, Chlumsky J, Vostatek P et al (2016) Airflow limitation is accompanied by diaphragm dysfunction. Physiol Res 65:469–479 [DOI] [PubMed] [Google Scholar]
- 7.Marino S, Bettini P, Pini L et al (2020) Effects of chronic and acute pulmonary hyperinflation on phrenic nerve conduction in patients with COPD. COPD 17:378–383 [DOI] [PubMed] [Google Scholar]
- 8.Figueira Silva BC, Abreu DC, Souza YR et al (2024) Ultrasonography as a way of evaluating the diaphragm muscle in patients with chronic obstructive pulmonary disease. Med (Baltim) 103:e39795 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang T, Liu Y, Wang M et al (2025) Diaphragm assessment by multimodal ultrasound imaging in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis 20:2629–2638 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shiraishi M, Higashimoto Y, Sugiya R et al (2020) Diaphragmatic excursion correlates with exercise capacity and dynamic hyperinflation in COPD patients. ERJ Open Res 6:00589–2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shiraishi M, Higashimoto Y, Sugiya R et al (2021) Diaphragmatic excursion is correlated with the improvement in exercise tolerance after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Respir Res 22:271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wada S, Matsuoka S, Mimura H (2022) Inspiratory and expiratory CT analyses of the diaphragmatic crus in chronic obstructive pulmonary disease. Jpn J Radiol 40:1257–1262 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Touchon F, Bermudez J, Habert P et al (2023) Change in diaphragmatic morphology in single-lung transplant recipients: a computed tomographic study. Front Physiol 14:1220463 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sukkasem W, Moftah SG, Kicska G et al (2017) Crus atrophy: accuracy of computed tomography in diagnosis of diaphragmatic paralysis. J Thorac Imaging 32:383–390 [DOI] [PubMed] [Google Scholar]
- 15.Shimizu K, Matsuzawa R, Nakamura S et al (2026) Prognostic significance of preoperative respiratory sarcopenia for functional recovery after cardiovascular surgery. Can J Cardiol 26:00129–00127 [DOI] [PubMed] [Google Scholar]
- 16.Tanimura K, Sato S, Fuseya Y et al (2016) Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Novel chest computed tomography-derived index for prognosis. Ann Am Thorac Soc 13:334–341 [DOI] [PubMed] [Google Scholar]
- 17.Higashimoto Y, Shiraishi M, Sugiya R et al (2021) Effect of Pulmonary rehabilitation on erector spinae muscles in individuals with COPD. Respir Care 66:1458–1468 [DOI] [PubMed] [Google Scholar]
- 18.Bakker JT, Hartman JE, Klooster K et al (2024) Automated evaluation of diaphragm configuration based on chest CT in COPD patients. Eur Radiol Exp 8:87 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tanabe N, Muro S, Hirai T et al (2011) Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:1653–1659 [DOI] [PubMed] [Google Scholar]
- 20.American Thoracic Society/European Respiratory S (2002) ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624 [DOI] [PubMed] [Google Scholar]
- 21.Redlich CA, Tarlo SM, Hankinson JL et al (2014) Official American Thoracic Society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med 189:983–993 [DOI] [PubMed] [Google Scholar]
- 22.Stanojevic S, Kaminsky DA, Miller MR et al (2022) ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 60:2101499 [DOI] [PubMed] [Google Scholar]
- 23.Kubota M, Kobayashi H, Quanjer PH et al (2014) Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig 52:242–250 [DOI] [PubMed] [Google Scholar]
- 24.Laboratories ATSCoPSfCPF (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117 [DOI] [PubMed] [Google Scholar]
- 25.Holland AE, Spruit MA, Troosters T et al (2014) An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 44:1428–1446 [DOI] [PubMed] [Google Scholar]
- 26.Singh SJ, Puhan MA, Andrianopoulos V et al (2014) An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 44:1447–1478 [DOI] [PubMed] [Google Scholar]
- 27.O’Donnell DE, Laveneziana P (2006) Physiology and consequences of lung hyperinflation in COPD. Eur Respiratory Rev 15:61–67 [Google Scholar]
- 28.Gagnon P, Guenette JA, Langer D et al (2014) Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 9:187–201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sato S, Miyazaki S, Tamaki A et al (2023) Respiratory sarcopenia: A position paper by four professional organizations. Geriatr Gerontol Int 23:5–15 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.




